Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial.

ABSTRACT:

SUBMITTER: Hannawi S 

PROVIDER: S-EPMC9731927 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature